B BioPulse
Regulatory Sep 08, 2026 · 1 min read · 14,591 views

FDA should require credentials for psychedelic providers, experts say

I

Isabella Hart

Editorial · Sep 08, 2026

FDA should require credentials for psychedelic providers, experts say

Mental health experts urged the FDA at a hearing to set training and prescribing standards for psychedelic therapies

Read Original Source Back to Feed

← Previous

Makary pushes for IRB reforms to catch China's speedy trial starts

Next →

ADARx targets $319M IPO as TRexBio, Retension join filing queue

Related Reading

Updated: Ultragenyx's new gene therapy will cost $3.95M
Regulatory

Updated: Ultragenyx's new gene therapy will cost $3.95M

Sep 24, 2026

Roivant's road to a potential blockbuster begins with FDA approval for Lisraya
Regulatory

Roivant's road to a potential blockbuster begins with FDA approval for Lisraya

Sep 22, 2026

FDA faces questions on 'America First' provisions in latest user fee agreement
Regulatory

FDA faces questions on 'America First' provisions in latest user fee agreement

Sep 21, 2026